These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells. Lima RT, Martins LM, Guimarães JE, Sambade C, Vasconcelos MH. Cancer Gene Ther; 2004 May; 11(5):309-16. PubMed ID: 15031723 [Abstract] [Full Text] [Related]
9. Regulation of HtrA2/Omi by X-linked inhibitor of apoptosis protein in chemoresistance in human ovarian cancer cells. Yang X, Xing H, Gao Q, Chen G, Lu Y, Wang S, Ma D. Gynecol Oncol; 2005 May; 97(2):413-21. PubMed ID: 15863139 [Abstract] [Full Text] [Related]
10. Role of XIAP in inhibiting cisplatin-induced caspase activation in non-small cell lung cancer cells: a small molecule Smac mimic sensitizes for chemotherapy-induced apoptosis by enhancing caspase-3 activation. Checinska A, Hoogeland BS, Rodriguez JA, Giaccone G, Kruyt FA. Exp Cell Res; 2007 Apr 01; 313(6):1215-24. PubMed ID: 17291493 [Abstract] [Full Text] [Related]
11. Heterotrimeric stimulatory GTP-binding proteins inhibit cisplatin-induced apoptosis by increasing X-linked inhibitor of apoptosis protein expression in cervical cancer cells. Cho EA, Oh JM, Kim SY, Kim Y, Juhnn YS. Cancer Sci; 2011 Apr 01; 102(4):837-44. PubMed ID: 21255191 [Abstract] [Full Text] [Related]
12. Cisplatin inhibits the expression of X-linked inhibitor of apoptosis protein in human LNCaP cells. Nomura T, Mimata H, Yamasaki M, Nomura Y. Urol Oncol; 2004 Apr 01; 22(6):453-60. PubMed ID: 15610860 [Abstract] [Full Text] [Related]
13. Multitarget siRNA inhibition of antiapoptotic genes (XIAP, BCL2, BCL-X(L)) in bladder cancer cells. Kunze D, Wuttig D, Fuessel S, Kraemer K, Kotzsch M, Meye A, Grimm MO, Hakenberg OW, Wirth MP. Anticancer Res; 2008 Apr 01; 28(4B):2259-63. PubMed ID: 18751404 [Abstract] [Full Text] [Related]
14. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo. Vogler M, Walczak H, Stadel D, Haas TL, Genze F, Jovanovic M, Gschwend JE, Simmet T, Debatin KM, Fulda S. Cancer Res; 2008 Oct 01; 68(19):7956-65. PubMed ID: 18829553 [Abstract] [Full Text] [Related]
15. Bcl-2 expression as a predictive marker of hormone-refractory prostate cancer treated with taxane-based chemotherapy. Yoshino T, Shiina H, Urakami S, Kikuno N, Yoneda T, Shigeno K, Igawa M. Clin Cancer Res; 2006 Oct 15; 12(20 Pt 1):6116-24. PubMed ID: 17062688 [Abstract] [Full Text] [Related]
16. A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma. Ndozangue-Touriguine O, Sebbagh M, Mérino D, Micheau O, Bertoglio J, Bréard J. Oncogene; 2008 Oct 09; 27(46):6012-22. PubMed ID: 18560353 [Abstract] [Full Text] [Related]
17. Expression of clusterin, XIAP and survivin, and their changes by camptothecin (CPT) treatment in CPT-resistant PC-3 and CPT-sensitive LNCaP cells. Mizutani K, Matsumoto K, Hasegawa N, Deguchi T, Nozawa Y. Exp Oncol; 2006 Sep 09; 28(3):209-15. PubMed ID: 17080014 [Abstract] [Full Text] [Related]
18. Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cells. Pu YS, Hour TC, Chuang SE, Cheng AL, Lai MK, Kuo ML. Prostate; 2004 Jul 01; 60(2):120-9. PubMed ID: 15162378 [Abstract] [Full Text] [Related]
19. Downregulation of XIAP expression induces apoptosis and enhances chemotherapeutic sensitivity in human gastric cancer cells. Tong QS, Zheng LD, Wang L, Zeng FQ, Chen FM, Dong JH, Lu GC. Cancer Gene Ther; 2005 May 01; 12(5):509-14. PubMed ID: 15706355 [Abstract] [Full Text] [Related]
20. Akt and XIAP regulate the sensitivity of human uterine cancer cells to cisplatin, doxorubicin and taxol. Gagnon V, Van Themsche C, Turner S, Leblanc V, Asselin E. Apoptosis; 2008 Feb 01; 13(2):259-71. PubMed ID: 18071906 [Abstract] [Full Text] [Related] Page: [Next] [New Search]